Nimalie D. Stone, MD, MS
Dr. Stone is the Medical Epidemiologist for Long-term Care in the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC). She is a Board-certified infectious disease physician who has a research and clinical background in managing infections and antibiotic resistant pathogens in post-acute and long-term care settings.
She completed her internal medicine residency at Johns Hopkins University followed by an infectious disease fellowship at Emory University. Prior to joining CDC, she spent several years providing clinical care and advising infection prevention and control programs for a long-term acute care hospital and affiliated nursing home within the Emory Healthcare system. She continues to hold a faculty appointment within in the Emory University Division of Infectious Diseases.
John M. Boyce, MD
John M. Boyce, MD is Clinical Professor of Medicine at Yale University School of Medicine and retired in May 2015 from his position as Director of Epidemiology and Infection Control at Yale-New Haven Hospital.
He received his MD degree from University of Washington School of Medicine, completed a fellowship in infectious diseases at Herman Hospital in Houston, and obtained his training in epidemiology in CDC’s Epidemic Intelligence Service.
Kurt B. Stevenson MD, MPH
Kurt B. Stevenson MD, MPH is a Professor of Medicine with tenure in the Division of Infectious Diseases at The Ohio State University (OSU) College of Medicine with a joint appointment in the Division of Epidemiology in the OSU College of Public Health. He is also the Associate Medical Director of the Department of Clinical Epidemiology for the OSU Wexner Medical Center where he is the Medical Director of the Antimicrobial Stewardship Program.
Susan Huang, MD MPH
Susan Huang, MD MPH is a Professor of Medicine in the Division of Infectious Diseases and Health Policy Research Institute at the University of California Irvine School of Medicine, and the Medical Director of Epidemiology and Infection Prevention at UC Irvine Health.
She received her MD degree from the Johns Hopkins University School of Medicine and her MPH degree from the Harvard School of Public Health in Quantitative Methods.
Mirian Dal Ben, MD, Msc
Dr. Mirian Dal Ben, MD, Msc is a Hospital Epidemiologist and Infectious Disease physician at Hospital Sírio Libanês, São Paulo, Brazil, and a Phd student at University of São Paulo. She graduated from Universidade Federal de Minas Gerais (Belo Horizonte, Brazil) in 2004 and completed her residency and training in Infectious Diseases at Universidade de São Paulo (São Paulo, Brazil) in 2008.
David A Nace, MD, MPH, CMD
David A. Nace, MD, MPH, CMD is a geriatrician and faculty member in the Division of Geriatric Medicine at the University of Pittsburgh. Dr. Nace serves as the Director of Long-Term Care (LTC) and Influenza Programs for the Division and is the Chief of Medical Affairs for UPMC Senior Communities, a network of 21 LTC facilities located in Western PA. He also serves as the Medical Director of Asbury Heights, a multilevel senior campus located in Mt Lebanon, PA. In his administrative roles, he chairs the UPMC Senior Communities' Pharmacy and Therapeutics and Infection Control Committees.
Andreas F. Widmer, MD, MS, FSHEA, FIDSA
Prof. Widmer earned his MD degree in Switzerland, where he completed his fellowship in internal medicine in several hospitals. He founded the specialty infectious diseases as the secretary of the Swiss Society for Infectious Diseases back in 1998. He was trained in hospital epidemiology by R. Wenzel, in Iowa, IA, USA, where he completed his master degree in epidemiology at the University of Iowa.
He is a core member in the "patient safety" program of the WHO, past President of the Swiss Society for Hospital Epidemiology, editorial advisory board member of the journal "Clinical Infectious Diseases". In addition, he is board member of the Society for Healthcare Epidemiology of America (SHEA) and member in the guidelines committee. Furthermore, he is a fellow of Infectious Disease Society of America (IDSA), and treasurer of the European Study Group on Nosocomial Infections (ESGNI).
Anthony D. Harris, MD, MPH, FIDSA, FSHEA
Please join us in welcoming Anthony D. Harris, MD, MPH, FIDSA, FSHEA as the SHEA President in 2015. Dr. Harris is an infectious disease physician, hospital epidemiologist, and tenured professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine.
Dr. Harris was the founder of the SHEA Research Network and served as its director from 2009 to 2013. He has served on SHEA's Board of Trustees since 2010, first as a councilor and now as president.
Aaron M. Milstone, MD, MHS
Aaron M. Milstone, MD, MHS, is an Associate Professor of Pediatrics and Epidemiology at The Johns Hopkins University. He is an Infectious Diseases consultant and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital, the Chair of the Pediatric Leadership Council of the Society for Healthcare Epidemiology of America (SHEA), and serves on multiple national committees and writing groups guiding practices to prevent healthcare associated infections (HAIs) and emergence of antibiotic resistance in children. He is an active member of the SHEA Research Committee and Chair of SHEA Research Network Review Committee.
L. Silvia Munoz-Price, MD, PhD
Dr. Munoz-Price is an Associate Professor of Clinical Medicine at the Institute for Health and Society, Medical College of Wisconsin, currently serving as the Enterprise Epidemiologist for Froedtert & the Medical College of Wisconsin.
She previously was the Hospital Epidemiologist for Jackson Memorial Hospital, one of the largest public hospitals in the US. Additionally, Dr. Munoz-Price holds a PhD in Epidemiology from University of Miami.
Graeme Forrest, MD
Graeme Forrest is an Associate Professor of Medicine in the Division of Infectious Disease at the Portland VA Healthcare System and Oregon Health and Science University. He is the director of the Antimicrobial Stewardship Program at both institutions.
Dr. Forrest received his medical degree from the University of Adelaide, Australia and after a 5 year period of surgical training moved to the United States. His internal medicine residency was at Columbus Hospital, Chicago and Infectious Diseases fellowship at the University of Maryland, Baltimore where he stayed on faculty after completion of the fellowship.
Edward J. Septimus, MD, FIDSA, FACP, FSHEA
Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. He is board certified in both internal medicine and infectious diseases.
His current position is Medical Director Infection Prevention and Epidemiology Clinical Services Group HCA Healthcare System. Previously was medical director of infectious diseases and employee health at Memorial Hermann Healthcare System until November 2005. He finished a 3 year term on the Board of Directors of the Infectious Diseases Society of America (IDSA) in 2009, and is on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement.
Gary Kravitz, MD, FACP, FIDSA, FSHEA
Dr. Gary Kravitz is Hospital Epidemiologist at United Hospital, St. Paul, MN. He is the founding partner of St. Paul Infectious Disease Associates (1982).
He was one of the first people to successfully initiate an antibiotic stewardship program at a private hospital (2002) and at a long-term acute care hospital (2008) Educational background: BS from Michigan, an MD for Northwestern, residency at Minnesota, and ID fellowship at University of Chicago.
Ron E. Polk, PharmD, FIDSA, FSHEA
Ron Polk is Emeritus Professor, School of Pharmacy and Affiliate Professor of Medicine at Virginia Commonwealth University.
He was a founding member of the American College of Clinical Pharmacy (ACCP); a founding member and past president of the Society of Infectious Diseases Pharmacists (SIDP), and has served on the ICAAC program committee and the editorial board of Antimicrobial Agents and Chemotherapy.
Robert Duncan, MD, MPH
Dr. Robert Duncan is Hospital Epidemiologist and Director of Infection Prevention & Control at Lahey Hospital & Medical Center in Burlington, MA and Associate Professor of Medicine at Tufts Medical School in Boston.
He received a BA from Wesleyan University, an MPH (Infectious Disease Epidemiology) from Yale University, and an MD from the University of Connecticut, followed by residency training at New England Deaconess Hospital and an Infectious Diseases fellowship at the Boston City, Boston University, and Boston VA hospitals.
Lisa Saiman, MD, MPH, FSHEA
Dr. Lisa Saiman, is a professor of pediatrics at Columbia University Medical Center and an attending physician at New York-Presbyterian (NYP) Morgan Stanley Children's Hospital. Dr. Salman's primary research and clinical interests are the infectious disease and microbiology issues in people with cystic fibrosis and healthcare-acquired infections, multidrug-resistant pathogens, and antimicrobial stewardship, particularly as related to infants hospitalized in the neonatal ICU.
Dr. Saiman has been selected as the SHEA Lectureship at IDWeek 2014, presenting on October 10, 2014: 3:45 – 4:15 p.m.
Eli Perencevich, MD, MS
Dr. Eli Perencevich is a tenured Professor of Internal Medicine and Epidemiology at the University of Iowa Carver College of Medicine as well as the Director of the Center for Comprehensive Access & Delivery Research and Evaluation (CADRE) at the Iowa City VA Health Care System. He was recently named Senior Associate for Infection Control Studies for VA's Office of Public Health's National Center for Occupational Health and Infection Control (COHIC).
Sharon B. Wright, MD, MPH
Dr. Sharon B. Wright is the Director of the Division of Infection Control/Hospital Epidemiology in the Silverman Institute for Health Care Quality and Safety at Beth Israel Deaconess Medical Center. She is an Assistant Professor in Medicine at Harvard Medical School and is on the faculty of the Division of Infectious Diseases at Beth Israel Deaconess Medical Center.
Dr. Wright received her medical degree from Columbia College of Physicians and Surgeons and her master’s degree in public health from the Harvard School of Public Health.
Carol E. Chenoweth, MD, MS
Dr. Chenoweth is Professor of Medicine, Division of Infectious Diseases, at the University of Michigan Health System and is a Clinical Professor in Epidemiology at the University of Michigan School of Public Health. She served as the UMHS Hospital Epidemiologist for over 20 years and currently acts as the Associate Director of the UMHS Antimicrobial Stewardship Team.
Dr. Chenoweth current serves as SHEA Treasurer and has held previous positions as member and chair of the Publications Committee, Annual Meeting Planning Committee, Awards Committee, and member of the 2010 5th Decennial International Conference on Healthcare-Associated Infections Planning Committee. She is also Associate Editor of Infection Control and Hospital Epidemiology.
Thomas R. Talbot, MD, MPH, FSHEA, FIDSA
Dr. Talbot is an Associate Professor of Medicine and Preventive Medicine at Vanderbilt University School of Medicine and also serves as the Chief Hospital Epidemiologist for Vanderbilt University Medical Center (VUMC) in Nashville, TN.
He graduated from Duke University in 1992 and Vanderbilt University School of Medicine in 1996. He completed his residency in Internal Medicine at Johns Hopkins in 1999 and then returned in 2000 to serve as an Assistant Chief of Service on the Osler Medical Service. He completed his training in Infectious Diseases at Vanderbilt in 2003, where he also received a Master of Public Health.